Cargando…

Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Detalles Bibliográficos
Autores principales: Derkay, Craig S., Wikner, Emily E., Pransky, Seth, Best, Simon R., Zur, Karen, Sidell, Douglas R., Klein, Adam, Rosen, Clark, Dikkers, Frederick G., Johnson, Romaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/
https://www.ncbi.nlm.nih.gov/pubmed/35543118
http://dx.doi.org/10.1002/lary.30180
_version_ 1785021725842341888
author Derkay, Craig S.
Wikner, Emily E.
Pransky, Seth
Best, Simon R.
Zur, Karen
Sidell, Douglas R.
Klein, Adam
Rosen, Clark
Dikkers, Frederick G.
Johnson, Romaine
author_facet Derkay, Craig S.
Wikner, Emily E.
Pransky, Seth
Best, Simon R.
Zur, Karen
Sidell, Douglas R.
Klein, Adam
Rosen, Clark
Dikkers, Frederick G.
Johnson, Romaine
author_sort Derkay, Craig S.
collection PubMed
description
format Online
Article
Text
id pubmed-10084367
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100843672023-04-11 Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why? Derkay, Craig S. Wikner, Emily E. Pransky, Seth Best, Simon R. Zur, Karen Sidell, Douglas R. Klein, Adam Rosen, Clark Dikkers, Frederick G. Johnson, Romaine Laryngoscope Triological Society Best Practice John Wiley & Sons, Inc. 2022-05-11 2023-01 /pmc/articles/PMC10084367/ /pubmed/35543118 http://dx.doi.org/10.1002/lary.30180 Text en © 2022 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Triological Society Best Practice
Derkay, Craig S.
Wikner, Emily E.
Pransky, Seth
Best, Simon R.
Zur, Karen
Sidell, Douglas R.
Klein, Adam
Rosen, Clark
Dikkers, Frederick G.
Johnson, Romaine
Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title_full Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title_fullStr Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title_full_unstemmed Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title_short Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
title_sort systemic use of bevacizumab for recurrent respiratory papillomatosis: who, what, where, when, and why?
topic Triological Society Best Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/
https://www.ncbi.nlm.nih.gov/pubmed/35543118
http://dx.doi.org/10.1002/lary.30180
work_keys_str_mv AT derkaycraigs systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT wikneremilye systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT pranskyseth systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT bestsimonr systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT zurkaren systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT sidelldouglasr systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT kleinadam systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT rosenclark systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT dikkersfrederickg systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy
AT johnsonromaine systemicuseofbevacizumabforrecurrentrespiratorypapillomatosiswhowhatwherewhenandwhy